IMPACT OF EMERGING HIF-PH INHIBITORS ON RENAL ANEMIA TREATMENT

被引：0
|
作者：
Khan, J. [1 ]
Blackstock, T. [2 ]
Privolnev, Y. [3 ]
Moore, R. [4 ]
机构：
[1] Decis Resources Grp, Burlington, MA USA
[2] Decis Resources Grp, London, England
[3] Decis Resources Grp, Toronto, ON, Canada
[4] Decis Resources Grp, Nashville, TN USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2824
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK26
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [1] A spotlight on using HIF-PH inhibitors in renal anemia
    Odawara, Motoki
    Nishi, Hiroshi
    Nangaku, Masaomi
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1291 - 1299
  • [2] Uncovering the potential of HIF-PH inhibitors to treat renal anemia
    Weiss, Meghan
    Regan, Stephen
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2405 - I2406
  • [3] RENAL ANEMIA TREATMENT IN THE US- HOW PAYER POLICIES AND PHYSICIAN PREFERENCES DRIVE PRESCRIBING AND HOW WILL THE EMERGING ORAL HIF-PH INHIBITORS INFLUENCE PAYERS AND PHYSICIANS?
    Khan, J.
    O'Connor, E.
    Moore, R.
    Lewis, C.
    Fletcher-Louis, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A520 - A520
  • [4] Suboptimal Treatment of Anemia in CKD Non-Dialysis Patients: What Role Will HIF-PH Inhibitors Play?
    Robinson, Jennifer
    Staudt, Meghan
    Hurtado, Tucker B.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 185 - 185
  • [5] WHAT TO EXPECT WITH THE POTENTIAL APPROVAL OF HIF-PH INHIBITORS IN DIALYSIS
    Staudt, Meghan
    Malone, Skylar
    Robinson, Jennifer
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S104 - S104
  • [6] Discovery of molidustat (BAY 85-3934): A small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia
    Beck, Hartmut
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [7] Discovery of Molidustat (BAY85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia
    Beck, Hartmut
    Jeske, Mario
    Thede, Kai
    Stoll, Friederike
    Flamme, Ingo
    Akbaba, Metin
    Ergueden, Jens-Kerim
    Karig, Gunter
    Keldenich, Joerg
    Oehme, Felix
    Militzer, Hans-Christian
    Hartung, Ingo V.
    Thuss, Uwe
    [J]. CHEMMEDCHEM, 2018, 13 (10) : 988 - 1003
  • [8] Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects
    Nagano, Nobuo
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (09) : 1047 - 1048
  • [9] Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF-PH inhibitors
    Yap, Desmond Y. H.
    McMahon, Lawrence P.
    Hao, Chuan-Ming
    Hu, Nan
    Okada, Hirokazu
    Suzuki, Yusuke
    Kim, Sung Gyun
    Lim, Soo Kun
    Vareesangthip, Kriengsak
    Hung, Chi-Chih
    Nangaku, Masaomi
    [J]. NEPHROLOGY, 2021, 26 (02) : 105 - 118
  • [10] Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects
    Nobuo Nagano
    [J]. Clinical and Experimental Nephrology, 2021, 25 : 1047 - 1048
12345